NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-3.96 Cr | ₹-27 Cr | ₹-2.88 Cr | ₹-20 Cr | ₹-21 Cr |
What is the latest Cash Flow from Investing Activities ratio of NATH BIOGENES (INDIA) ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2025 | ₹-3.96 Cr |
Mar2024 | ₹-27 Cr |
Mar2023 | ₹-2.88 Cr |
Mar2022 | ₹-20 Cr |
Mar2013 | ₹-21 Cr |
How is Cash Flow from Investing Activities of NATH BIOGENES (INDIA) Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-3.96 Cr | Negative | |
Mar2024 | ₹-27 Cr | Negative | |
Mar2023 | ₹-2.88 Cr | Negative | |
Mar2022 | ₹-20 Cr | Negative | |
Mar2013 | ₹-21 Cr | - |
Compare Cash Flow from Investing Activities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹326.2 Cr | -1.9% | -5.7% | -23.4% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,727.4 Cr | 3.1% | -3.8% | -29.4% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,041.5 Cr | 2.6% | 5.6% | 13.4% | Stock Analytics | |
VENKYS (INDIA) | ₹2,108.7 Cr | 0.8% | -1% | -35.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,477.9 Cr | -2.4% | 4.3% | -28.4% | Stock Analytics | |
INDO US BIOTECH | ₹294.8 Cr | -1% | -16.1% | -45.9% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -1.9% |
-5.7% |
-23.4% |
SENSEX | -1.8% |
-1.6% |
-2% |
You may also like the below Video Courses